Overview

Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma

Status:
Terminated
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of capecitabine in patients who have undergone a total gastrectomy.
Phase:
Phase 4
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Treatments:
Capecitabine